Louise A. Brinton, Ph.D., M.P.H., has been appointed Scientific Advisor for International Activities in the DCEG Office of the Director. In this new position, Dr. Brinton will utilize her extensive experience in leading epidemiologic studies around the globe. She will review and advise on plans for studies in other countries, assess the progress of ongoing studies, evaluate resources, and coordinate with other entities across NIH and elsewhere that are involved with global health activities. In addition, she will continue to conduct independent research through DCEG’s Epidemiology and Biostatistics Program.
Dr. Brinton had been serving since 1996 as Chief of the Hormonal and Reproductive Epidemiology Branch (HREB). Her research focuses on the epidemiology of breast (both female and male), endometrial and ovarian malignancies. She has had a special interest in defining the role of both endogenous and exogenous hormones in these cancers and in addressing etiologic heterogeneity within the tumors. In addition, she has collaborated on a number of projects to identify biomarkers (including genetic markers) for these malignancies.
“I commend Louise for her stellar leadership of HREB, which contributed much of what we know about the epidemiology of hormonally–related cancers, cancers of the reproductive system, and other malignancies,” said Stephen J. Chanock, M.D., Director of DCEG.
Dr. Brinton has earned numerous awards and honors throughout her career. She received the U.S. Public Health Service Special Recognition Award and the NIH Director's Award for innovative leadership in women's health research. She has also been honored by receipt of the H.A. Tyroler Distinguished Alumni Award from the University of North Carolina, the American College of Epidemiology’s Abraham Lilienfeld Award, and the Society for Epidemiologic Research Career Accomplishment Award.